Personalized brain stimulation for major depression
Part of Mental health clinical trials.
This trial tests a new form of brain stimulation called iTBS (a type of repetitive transcranial magnetic stimulation) that is personalized for each person, compared to a sham (inactive) treatment. It aims to see if this personalized approach can safely reduce symptoms of depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 22 and 65 years old and right-handed.
- You must have a diagnosis of major depressive disorder (confirmed by a clinical interview).
- Your current depressive episode must have lasted at least 4 weeks.
- Your depression must be moderate to severe (score of 20 or higher on a standard depression rating scale).
- You can be medication-free or on a stable dose of psychiatric medication for at least 4 weeks before starting.
- You must be able to undergo MRI scans and EEG recordings (no metal implants, pacemakers, or claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of delivering a non-invasive brain stimulation treatment called iTBS for depression. The treatment is personalized based on brain scans, and the study aims to see if it can help reduce depressive symptoms.
This study uses brain imaging to guide a noninvasive treatment called transcranial magnetic stimulation (TMS) for people with depression. It aims to see if tailoring the stimulation to each person's brain can improve symptoms.
This trial tests a new type of brain stimulation called theta-burst stimulation to see if it helps treat depression. It is for people aged 18-50 who are currently experiencing a major depressive episode and are on a stable antidepressant regimen.
This study tests a new type of brain stimulation that uses gentle electrical fields to target the area of the brain linked to emotions. It may help reduce depression symptoms without the side effects of medications.
This trial tests a new type of non-invasive brain stimulation that uses gentle electrical fields to target areas of the brain linked to mood. It aims to help people with moderate to severe depression who haven't responded well to other treatments.
This study tests a personalized, maintenance brain-stimulation treatment (called accelerated TMS) that is fine-tuned for each person to help keep depression from coming back. It also uses wrist-worn sensors and phone surveys to track mood and catch signs of depression early so you can get help sooner.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.